This issue's highlights are:
The concept behind this newsletter is that anyone with 15 minutes to spare can learn about the work of the Centre for Epidemic Research and Innovation (CERI) at Stellenbosch University and the KwaZulu-Natal Research Innovation and Sequencing Platform (KRISP), which is a Platform of the Technology Innovation Agency (TIA) at University of KwaZulu-Natal (UKZN), Durban, South Africa.
- News: Are COVID surges becoming more predictable?
- News: New versions of Omicron are masters of immune evasion
- News: Professor Tulio de Oliveira and Dr. Sikhulile Moyo on being listed in the Time magazines 100 most influential people of 2022
- Publication: African science should have a central place on the world stage
- Publication: An early warning system for emerging SARS-CoV-2 variants
- Publication: Omicron infection enhances Delta antibody immunity in vaccinated persons
- Announcement: Masters and PhD Positions in in HIV drug resistance at KRISP, UKZN
- Announcement: Laboratory technician vacancies at CERI
- Events: Virtual conference on SARS-CoV-2 Sequencing in Africa. Lessons From the 100,000 Genomes
- Seminar: Digital Health Computing, Information Systems and Machine Learning for Public Health, Prof Douglas Pires, 22 June 2022
CERI and KRISP want to want to challenge the status quo and create a scientific environment in South Africa that drives innovations in global health and reverses the brain drain. A critical function of CERI and KRISP will be to make genomics, epigenetics, and bioinformatics accessible to academic, industrial, and commercial users.
News date: 2022-06-02
KRISP has been created by the coordinated effort of the University of KwaZulu-Natal (UKZN), the Technology Innovation Agency (TIA) and the South African Medical Research Countil (SAMRC).
Location: K-RITH Tower Building
Nelson R Mandela School of Medicine, UKZN
719 Umbilo Road, Durban, South Africa.
Director: Prof. Tulio de Oliveira